Both in Pharmaceuticals
Alto Neuroscience vs Obsidian Therapeutics
Over the past year ANRO returned −28.4% and OBX returned −16.7%; their daily moves had a correlation of 0.50.
ANRO −28.4% OBX −16.7%Growth of $1, one year, split-adjusted
| Metric | ANRO | OBX |
|---|---|---|
| Price | $22.91 | $14.83 |
| Market cap | $898.8M | $915.8M |
| Today | −1.23% | +4.04% |
| 1 month | −13.8% | +1.7% |
| 6 months | −5.7% | — |
| Year to date | +28.7% | — |
| 1 year | +87.0% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $225.1M | — |
| Dividend yield | — | — |
| Volatility (60d) | 55.7% | — |
| Short % of float | 20.0% | 2.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).